Studying of Thyroid Dysfunction on Patients with Metabolic Syndrome

Abstract

A retrospective study was conducted several studies aimed at knowing the relationship between the level of thyroid hormone and the metabolic syndrome and according to the results of the study, it is recommended to determine the level of tsh hormone in the pituitary gland in all patients as well as in all patients with risks of developing cardiovascular diseases: in patients who they suffer from obesity, dyslipidemia, arterial hypertension, hyperhomocysteinemia, and tobacco smoking., hereditary factor, diabetes mellitus type 2. No less important is the issue of treatment tactics in patients and in accordance with current recommendations, the appointment of thyroid hormone preparations is indicated for patients with an increase in the level of tsh more than 10 μm / l. The assignment of thyroxine to the boundary level of tsh is still a matter of debate. Most authors consider surgical myocardial revascularization, continuous statin therapy, and correction of subclinical hypothyroidism with small doses of thyroxine to normal tsh values as ideal. The most appropriate is the early detection of subclinical hypothyroidism in patients and correction of disorders identified with thyroid hormone preparations. The study showed that subclinical hypothyroidism is an additional independent risk factor.